NSCLC is a highly heterogeneous malignancy with a poor prognosis. Treatment for NSCLC is currently based on a combination of pathological staging and histological classification. Recently, gene expression-based NSCLC profiling is proven a superior approach to stratify cancer cases with different prognosis and to sub-classify patients in respect of response to chemotherapy. The goal of the work described in this thesis is to explore the possible application of expression profiling in oncological practice.

, , ,
Cancer Genomics Centre (CGC), Netherlands Bioinformatics Centre (NBIC), Netherlands Consortium for System Biology (NCSB), Netherlands Proteomics Centre (NPC)
F.G. Grosveld (Frank) , J.N.J. Philipsen (Sjaak)
Erasmus University Rotterdam
Erasmus MC: University Medical Center Rotterdam

Hou, J. (2010, January 13). Gene Expression Profiling of Early Stage Non-Small Cell Lung Cancer. Retrieved from http://hdl.handle.net/1765/17731